T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity
Diffuse intrinsic pontine glioma (DIPG) remains the main cause of death in children with brain tumors. Given the inefficacy of numerous peripherally delivered agents to treat DIPG, convection enhanced delivery (CED) of therapeutic agents is a promising treatment modality. The purpose of this study was to determine which MR imaging type provides the best discrimination of intratumoral heterogeneity to guide future stereotactic implantation of CED catheters into the most cellular tumor regions.
Patients ages 18 years or younger with a diagnosis of DIPG from 2000 to 2015 were included. Radiographic heterogeneity index (HI) of the tumor was calculated by measuring the standard deviation of signal intensity of the tumor (SDTumor) normalized to the genu of the corpus callosum (SDCorpus Callosum). Four MR image types (T2-weighted, contrast-enhanced T1-weighted, FLAIR, and ADC) were analyzed at several time points both before and after radiotherapy and chemotherapy. HI values across these MR image types were compared and correlated with patient survival.
MR images from 18 patients with DIPG were evaluated. The mean survival ± standard deviation was 13.8 ± 13.7 months. T2-weighted images had the highest HI (mean ± SD, 5.1 ± 2.5) followed by contrast-enhanced T1-weighted images (3.7 ± 1.5), FLAIR images (3.0 ± 1.1), and ADC maps (1.6 ± 0.4). ANOVA demonstrated that HI values were significantly higher for T2-weighted images than FLAIR (p < 0.01) and ADC (p < 0.0001). Following radiotherapy, T2-weighted and contrast-enhanced T1-weighted image HI values increased, while FLAIR and ADC HI values decreased. Univariate and multivariate analyses did not reveal a relationship between HI values and patient survival (p > 0.05).
For children with DIPG, T2-weighted MRI demonstrates the greatest signal intensity variance suggesting tumor heterogeneity. Within this heterogeneity, T2-weighted signal hypointensity is known to correlate with increased cellularity and thus may represent a putative target for CED catheter placement in future clinical trials.
KeywordsDiffuse intrinsic pontine glioma DIPG MRI T2 Tumor heterogeneity Convection enhanced delivery
The authors wish to thank Kristy Averette, RN, for assistance with the IRB submission.
Concept and design: Farber, Harward, Becher, Thompson. Acquisition of data: Farber and Harward. Analysis and interpretation of data: all authors. Drafting the article: Farber, Harward, Malinzak, Thompson. Critically revising the article: all authors. Statistical analysis: Farber, Harward, Thompson. Final manuscript approval on behalf of all authors: Thompson.
Compliance with ethical standards
Conflict of interest
The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
- 1.Poussaint TY, Vajapeyam S, Ricci KI, Panigrahy A, Kocak M, Kun LE, Boyett JM, Pollack IF, Fouladi M (2016) Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium. Neuro-Oncology 18(5):725–734. https://doi.org/10.1093/neuonc/nov256 CrossRefPubMedGoogle Scholar
- 7.Bradley KA, Pollack IF, Reid JM, Adamson PC, Ames MM, Vezina G, Blaney S, Ivy P, Zhou T, Krailo M, Reaman G, Mehta MP, Group Cs (2008) Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children’s Oncology Group phase I study. Neuro-Oncology 10(5):752–758. https://doi.org/10.1215/15228517-2008-043 CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Bredlau AL, Korones DN (2014) Diffuse intrinsic pontine gliomas: treatments and controversies. Adv Cancer Res 121:235–259. https://doi.org/10.1016/B978-0-12-800249-0.00006-8 CrossRefPubMedGoogle Scholar
- 10.Lonser RR, Walbridge S, Garmestani K, Butman JA, Walters HA, Vortmeyer AO, Morrison PF, Brechbiel MW, Oldfield EH (2002) Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg 97(4):905–913. https://doi.org/10.3171/jns.2002.97.4.0905 CrossRefPubMedGoogle Scholar
- 15.Lonser RR, Warren KE, Butman JA, Quezado Z, Robison RA, Walbridge S, Schiffman R, Merrill M, Walker ML, Park DM, Croteau D, Brady RO, Oldfield EH (2007) Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 107(1):190–197. https://doi.org/10.3171/JNS-07/07/0190 CrossRefPubMedGoogle Scholar
- 16.Kornreich L, Schwarz M, Karmazyn B, Cohen IJ, Shuper A, Michovitz S, Yaniv I, Fenig E, Horev G (2005) Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature. Pediatr Radiol 35(9):872–879. https://doi.org/10.1007/s00247-005-1502-y CrossRefPubMedGoogle Scholar
- 20.Clerk-Lamalice O, Reddick WE, Li X, Li Y, Edwards A, Glass JO, Patay Z (2016) MRI evaluation of non-necrotic T2-hyperintense foci in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol. https://doi.org/10.3174/ajnr.A4814
- 21.Conway AE, Reddick WE, Li Y, Yuan Y, Glass JO, Baker JN, Kun LE, Broniscer A, Patay Z (2014) “Occult” post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis? Neuroradiology 56(5):405–412. https://doi.org/10.1007/s00234-014-1348-9 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Löbel U, Sedlacik J, Reddick WE, Kocak M, Ji Q, Broniscer A, Hillenbrand CM, Patay Z (2011) Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 32(2):315–322. https://doi.org/10.3174/ajnr.A2277 CrossRefPubMedGoogle Scholar
- 23.Löbel U, Sedlacik J, Sabin ND, Kocak M, Broniscer A, Hillenbrand CM, Patay Z (2010) Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma. Neuroradiology 52(12):1167–1177. https://doi.org/10.1007/s00234-010-0771-9 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer RJ, Chi SN, da Silva N, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29(30):3999–4006. https://doi.org/10.1200/JCO.2011.35.5677 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Poussaint TY, Kocak M, Vajapeyam S, Packer RI, Robertson RL, Geyer R, Haas-Kogan D, Pollack IF, Vezina G, Zimmerman R, Cha S, Patay Z, Boyett JM, Kun LE (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro-Oncology 13(4):417–427. https://doi.org/10.1093/neuonc/noq200 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Lober RM, Cho Y-JJ, Tang Y, Barnes PD, Edwards MS, Vogel H, Fisher PG, Monje M, Yeom KW (2014) Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. J Neuro-Oncol 117(1):175–182. https://doi.org/10.1007/s11060-014-1375-8 CrossRefGoogle Scholar
- 28.Oh J, Cha S, Aiken AH, Han ET, Crane JC, Stainsby JA, Wright GA, Dillon WP, Nelson SJ (2005) Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging : JMRI 21(6):701–708. https://doi.org/10.1002/jmri.20335 CrossRefPubMedGoogle Scholar